Home › Zydus Explores Newer Treatment Options With Its Breakthrough Drug, Lipaglyn
 

Keywords :   


Zydus Explores Newer Treatment Options With Its Breakthrough Drug, Lipaglyn

2014-06-04 12:25:12| drugdiscoveryonline Home Page

Exploring newer therapeutic usage of its breakthrough drug Lipaglyn™ (Saroglitazar), the Zydus Group has now initiated Phase III trials of the molecule for patients suffering from lipodystrophy

Tags: options treatment drug newer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
More »